What is the primary difference between first-line and last-resort antibiotics in the context of resistance?

First-line antibiotics are the preferred, usually safer and cheaper treatments for susceptible infections. Last-resort antibiotics are used only when others fail; they are often more expensive, more toxic to the patient, and reserved to prevent further resistance development.

How does the impact of antibiotic resistance differ for an individual patient versus a healthcare system?

For an individual, resistance leads to longer recovery times and higher mortality risk. For the healthcare system, it results in massive economic strain, the need for specialized isolation wards, and the potential loss of safety for routine surgical procedures.

Compare the role of 'selection pressure' in susceptible versus resistant bacterial populations.

In susceptible populations, antibiotic selection pressure eliminates the majority of individuals. In populations containing resistant mutants, the same pressure removes competitors, allowing the resistant individuals to thrive and pass on their resistance alleles.

Why is it incorrect to say that 'antibiotics cause bacteria to mutate'?

Mutations are random, spontaneous events that occur during DNA replication regardless of antibiotic presence. Antibiotics do not induce the mutation; they simply act as a filter that selects for the survival of bacteria that already possess a beneficial mutation.

What is the common misconception regarding who is affected by antibiotic resistance?

Many believe resistance only affects people who take too many antibiotics. In reality, resistance is a property of the bacteria, not the human; anyone can be infected by a resistant strain (like MRSA) regardless of their personal antibiotic history.

What error is made when describing the genetic change leading to resistance?

Students often incorrectly state that a 'new gene' is created. It is more accurate to say a mutation creates a 'new allele' of an existing gene, or that a resistance gene is acquired from another bacterium via horizontal gene transfer.

Define the term 'Superbug' in a clinical context.

A superbug is a strain of bacteria that has accumulated resistance to multiple different antibiotics, often across several drug classes. This makes infections caused by these bacteria extremely difficult and expensive to treat.

What does the acronym MRSA stand for, and why is it significant?

MRSA stands for Methicillin-resistant Staphylococcus aureus. It is significant because it is a widespread resistant strain that frequently causes difficult-to-treat infections in hospitals, particularly in surgical wounds.

What is 'Multi-drug Resistance' (MDR)?

MDR refers to a condition where a bacterial species is resistant to at least one antibiotic in three or more antimicrobial categories. This significantly limits the available therapeutic options for a patient.

Why does antibiotic resistance threaten the success of chemotherapy?

Chemotherapy often suppresses the patient's immune system, making them highly vulnerable to infections. If the antibiotics used to protect these patients are ineffective due to resistance, minor infections can become fatal.

Consequences of Antibiotic Resistance | Cambridge International Examinations AS-Level Biology

Revision Notes

AS-Level

Cambridge International Examinations

Biology

10. Infectious Diseases

Consequences of Antibiotic Resistance

Summary

Antibiotic resistance (AR) represents a critical shift in global health where bacterial evolution outpaces medical intervention. The primary consequences involve the failure of standard treatments, the emergence of multi-drug resistant 'superbugs', and a significant increase in the complexity and cost of healthcare, which threatens the safety of routine medical procedures.

1. Definition & Core Concepts

Antibiotic Resistance (AR) occurs when bacterial populations evolve mechanisms to survive exposure to drugs designed to kill them or inhibit their growth.
The core consequence is the loss of clinical efficacy for commonly prescribed antibiotics, meaning infections that were once easily managed become persistent or life-threatening.
This process is driven by selection pressure, where the use of antibiotics kills susceptible bacteria but allows resistant individuals to survive and proliferate.

2. Clinical Impact: The Rise of Superbugs

Superbugs are bacterial strains that have developed resistance to multiple classes of antibiotics, making them exceptionally difficult to eradicate.
A primary example is MRSA (Methicillin-resistant Staphylococcus aureus), which has adapted to survive treatments that were previously standard for skin and wound infections.
When first-line treatments fail, clinicians must resort to multiple-antibiotic therapies or 'last-resort' drugs, which often carry higher risks of side effects and toxicity.

Flowchart showing the escalation from standard infection to treatment failure and the subsequent need for complex multi-drug therapy.

3. Economic and Accessibility Challenges

Treating resistant infections is significantly more expensive due to the need for specialized drugs, extended hospital stays, and intensive laboratory monitoring.
There is a growing inequality in healthcare, as these high-cost treatments may not be accessible to populations in developing regions or those without comprehensive insurance.
The development of new antibiotics is a slow, high-risk, and costly financial investment for pharmaceutical companies, leading to a 'discovery void' where few new drugs reach the market.

4. Risks to Surgical and Medical Procedures

5. Key Distinctions: Susceptible vs. Resistant Strains

6. Exam Strategy & Tips